Press release
Persistent Epithelial Defects (PEDs) Market to Reach USD 2.3 Billion by 2034
Persistent Epithelial Defects
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72239
Traditionally, treatment options have included lubrication, bandage contact lenses, and tarsorrhaphy. However, advances in regenerative medicine, biologics, and growth factor-based therapies are revolutionizing the management of PEDs. Rising awareness among ophthalmologists, coupled with investments in advanced ocular care and patient-centric innovations, are creating new opportunities in this specialized market.
Market Overview
According to Exactitude Consultancy, the global Persistent Epithelial Defects (PEDs) Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.3 billion by 2034, growing at a CAGR of 6.5% between 2025 and 2034.
Key Highlights
• Growing disease recognition: Increasing awareness of ocular surface disorders is improving diagnosis rates.
• Drivers: Advancements in biologics, regenerative therapies, and stem cell solutions.
• Challenges: High treatment costs, limited donor tissue availability, and underdiagnosis in developing regions.
• Leading players: Dompé, Johnson & Johnson Vision, Novartis, Bausch + Lomb, and Regeneron are spearheading therapeutic innovation.
Segmentation Analysis
The persistent epithelial defects market can be segmented by treatment type, end use, and region.
By Treatment Type
• Conventional therapies (lubricants, bandage contact lenses)
• Biologics (growth factors, amniotic membrane products)
• Regenerative therapies (stem cell-based treatments, platelet-rich plasma)
• Surgical interventions (tarsorrhaphy, keratoplasty)
By End Use
• Hospitals
• Specialty eye clinics
• Ambulatory surgical centers
• Research and academic institutions
Segmentation Summary
While conventional therapies remain widely used for early-stage management, biologics and regenerative therapies are the fastest-growing segments, offering superior healing potential and reduced complications. Amniotic membrane grafts and growth factor-based eye drops are becoming standard in refractory cases, while regenerative and stem cell therapies represent the future of PEDs treatment.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72239/persistent-epithelial-defects-market
Regional Analysis
North America
• Largest market share, driven by advanced healthcare systems, high diagnosis rates, and robust R&D in ophthalmology.
• The U.S. leads with FDA approvals for innovative therapies and strong investment in regenerative medicine.
Europe
• Significant adoption in Germany, France, and the U.K.
• EU initiatives in rare and chronic eye disease research are accelerating the introduction of new biologics.
Asia-Pacific
• Expected to record the fastest CAGR during 2025-2034.
• Large patient pool in China and India, rising prevalence of ocular surface disorders, and expanding access to advanced therapies fuel growth.
• Japan and South Korea lead in adopting novel regenerative and stem cell-based treatments.
Middle East & Africa
• Moderate growth, with GCC countries driving demand through investments in specialized ophthalmology centers.
• Affordability and lack of widespread diagnosis remain barriers in African markets.
Latin America
• Brazil and Mexico dominate with improving healthcare infrastructure and expanding access to biologic therapies.
Regional Summary
While North America dominates today, Asia-Pacific is projected to grow fastest, fueled by demographic changes, healthcare modernization, and rising adoption of biologics and regenerative therapies.
Market Dynamics
Key Growth Drivers
1. Advances in regenerative therapies - Stem cell and platelet-rich plasma therapies offer promising solutions for refractory PEDs.
2. Innovation in biologics - Amniotic membrane-based products and growth factor eye drops are transforming healing outcomes.
3. Rising awareness of ocular diseases - Improved screening and education campaigns are expanding early diagnosis and treatment.
4. Supportive regulatory frameworks - Orphan drug designations and accelerated approvals for rare ocular diseases.
Key Challenges
1. High costs of advanced therapies - Regenerative and biologic treatments remain expensive, limiting accessibility in lower-income regions.
2. Limited donor tissue availability - Amniotic membrane supply and corneal donor shortages affect treatment scalability.
3. Underdiagnosis - Many cases are misdiagnosed as chronic dry eye, delaying appropriate intervention.
Latest Trends
• Biologic innovations: Growth factor-based eye drops and recombinant biologics are gaining traction.
• Stem cell therapies: Research into limbal stem cell transplantation is advancing rapidly.
• Digital ophthalmology: Teleophthalmology platforms support wider screening and management of PEDs.
• Collaborative research: Pharma-academic partnerships are accelerating innovation in regenerative solutions.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72239
Competitor Analysis
Major Players in the Persistent Epithelial Defects Market
• Dompé Farmaceutici S.p.A.
• Johnson & Johnson Vision
• Novartis AG
• Bausch + Lomb
• Regeneron Pharmaceuticals, Inc.
• Allergan (AbbVie Inc.)
• Alcon Inc.
• MediTox Inc.
• Kedrion Biopharma
• Santen Pharmaceutical Co., Ltd.
Competitive Dynamics
Dompé leads with cenegermin (Oxervate), the first FDA-approved treatment for neurotrophic keratitis, a major cause of PEDs. Johnson & Johnson Vision and Novartis focus on biologic eye care products, while Regeneron and Allergan expand pipelines in ocular biologics. Regional firms and startups are innovating in regenerative medicine and cell-based therapies, particularly in Asia-Pacific. Strategic alliances and orphan drug designations are central to competitive positioning.
Conclusion
The Persistent Epithelial Defects (PEDs) Market is projected to nearly double in size, growing from USD 1.2 billion in 2024 to USD 2.3 billion by 2034, at a CAGR of 6.5%.
Key opportunities include:
• Expanding adoption of biologic therapies and regenerative medicine.
• Accelerating stem cell and growth factor innovations.
• Leveraging digital ophthalmology platforms to improve diagnosis and management.
• Strengthening awareness and access in emerging markets.
While cost and donor tissue limitations remain significant barriers, continued advancements in biologics and regenerative solutions are reshaping the future of PEDs treatment.
In conclusion, the PEDs market is entering a transformative decade where innovation in biologics, regenerative therapies, and digital health will expand treatment access, improve outcomes, and create significant opportunities for stakeholders across the ophthalmology sector.
This report is also available in the following languages : Japanese (持続性上皮欠損市場), Korean (지속성 상피 결손 시장), Chinese (持续性上皮缺陷市场), French (Marché des défauts épithéliaux persistants), German (Markt für anhaltende Epitheldefekte), and Italian (Mercato dei difetti epiteliali persistenti), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72239/persistent-epithelial-defects-market#request-a-sample
Our More Reports:
CRISPR Gene Editing in Infectious Diseases: Market
https://exactitudeconsultancy.com/reports/73646/crispr-gene-editing-in-infectious-diseases-market
Parkinson's Disease in 68 Market
https://exactitudeconsultancy.com/reports/73647/parkinson-s-disease-in-68-market
Respiratory Syncytial Virus Prophylaxis Market
https://exactitudeconsultancy.com/reports/73648/respiratory-syncytial-virus-prophylaxis-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Persistent Epithelial Defects (PEDs) Market to Reach USD 2.3 Billion by 2034 here
News-ID: 4191798 • Views: …
More Releases from Exactitude Consultancy
Wet Age-Related Macular Degeneration (Wet AMD) market is expected to reach USD 1 …
Wet age-related macular degeneration (Wet AMD) is a chronic, progressive eye disorder and one of the leading causes of severe vision loss in people over 60. Unlike the dry form of AMD, Wet AMD is characterized by the growth of abnormal blood vessels under the retina that leak fluid or blood, leading to rapid central vision loss. While Wet AMD accounts for only about 10-15% of all AMD cases, it…
Allergic conjunctivitis Market could reach USD 7.5 billion by 2034
Allergic conjunctivitis (AC) is one of the most common ocular surface disorders, caused by hypersensitivity reactions to allergens such as pollen, dust, animal dander, and environmental pollutants. It manifests with symptoms like redness, itching, tearing, and swelling, often recurring seasonally or persisting year-round in chronic cases. While not vision-threatening, allergic conjunctivitis significantly impacts patient comfort, quality of life, and productivity, making effective treatment essential.
Download Full PDF Sample Copy of Market…
Spinal Cord Injury Market to Expand at 5.2% CAGR, Reaching USD 10.8 Billion by 2 …
Introduction
Spinal cord injury (SCI) is a devastating condition that results in partial or complete loss of motor and sensory function below the site of injury. The primary causes include traumatic events such as motor vehicle accidents, falls, sports injuries, and violence, as well as non-traumatic causes like tumors or degenerative diseases.
Beyond its immediate medical impact, SCI has profound social and economic consequences, requiring long-term rehabilitation, assistive technologies, and lifelong care.…
Vagus Nerve Stimulator Market to Grow at 6.8% CAGR, Reaching USD 1.25 Billion by …
Introduction
Vagus nerve stimulation (VNS) is a neuromodulation therapy that uses electrical impulses delivered to the vagus nerve to regulate brain activity. Initially approved for drug-resistant epilepsy, VNS has since expanded into treatments for depression, migraine, cluster headaches, and inflammatory conditions.
With rising cases of neurological and psychiatric disorders, the growing preference for non-pharmacological therapies, and ongoing innovation in implantable and non-invasive devices, the vagus nerve stimulator market is positioned for significant…
More Releases for PEDs
Hosiery Market Hits New High | Major Giants Jockey, Fruit of the Loom, Peds
HTF MI just released the Global Hosiery Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Players in This Report Include:
Hanesbrands, Calvin Klein, Nike, Adidas, L'eggs, Burlington,…
Persistent Epithelial Defects Pipeline Insight 2025: Regenerative Biologics, Nov …
The therapeutic pipeline for persistent epithelial defects (PEDs) is expanding, with a focus on regenerative and targeted therapies. Current treatments often offer only temporary relief, leaving patients at risk of serious complications. This highlights the need for durable, mechanism-based solutions to restore ocular surface health.
DelveInsight's "Persistent Epithelial Defects - Pipeline Insight, 2025 [https://www.delveinsight.com/report-store/persistent-corneal-epithelial-defects-pceds-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]" highlights an emerging wave of candidates designed to enhance corneal healing and prevent complications. Recombinant growth factors…
Toddler Development Assessment Tool Market Size, Outlook And Industry Analysis R …
The Global Toddler Development Assessment Tool Market report is added by WMR to its database to offer a complete assessment of the factors influencing an overall market growth trend. The research covers significant data and proves to be a handy resource document for industry experts. The research is a perfect balance bridging both qualitative and quantitative information of this market. Quantitative statistics with qualitative reasoning related to market size, share,…
Persistent Epithelial Defect Drugs Market Size 2032 | Dompe Farmaceutici, OcuNex …
DelveInsight's "Persistent Epithelial Defect Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Persistent Epithelial Defect (PEDs), historical and forecasted epidemiology as well as the Persistent Epithelial Defect (PEDs) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Key Takeaways from the Persistent Epithelial Defects Market Report
• The increase in Persistent Epithelial Defect market size is a direct consequence of…
Toddler Development Assessment Tool Market 2023 Booming Across the Globe by Grow …
The Toddler Development Assessment Tool Market Trends Overview 2023-2030:
A new Report by Worldwide Market Reports, titled "Toddler Development Assessment Tool Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," offers a comprehensive analysis of the industry, which comprises insights on the Toddler Development Assessment Tool market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
This report has a complete table of contents, figures,…
Platform Edge Doors (PEDs) Market 2023 Driving Factors Forecast Research 2029
This comprehensive report thoroughly assesses various regions, estimating the volume of the global Platform Edge Doors (PEDs) market within each region during the projected timeframe. The report is meticulously crafted and includes valuable information on the current market status, historical data, and projected outlook. Furthermore, it presents a detailed market analysis, segmenting it based on regions, types, and applications. The report closely monitors key trends that play a crucial role…
